Duality Biotherapeutics gains Shanghai Stock Exchange acceptance for STAR Market A-share IPO

Bulletin Express06-12 22:42

Duality Biotherapeutics, Inc. announced that the Shanghai Stock Exchange (SSE) has formally accepted the company’s application materials for an initial public offering of RMB ordinary shares (A Shares) on the Science and Technology Innovation Board (STAR Market). The submission includes the “Initial Public Offering of RMB Ordinary Shares (A Shares) and Listing on the Science and Technology Innovation Board Prospectus (Application Proof),” which will be available on the SSE website.

The proposed RMB Share Issue remains subject to subsequent regulatory approvals and therefore may or may not proceed. Duality Biotherapeutics emphasized that shareholders and potential investors should exercise caution when dealing in the company’s shares.

Further updates will be released in accordance with Hong Kong Listing Rules and other applicable regulations.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1198994923?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-12 22:42","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1198994923","market":"us","top_or_hot":-1,"title":"Duality Biotherapeutics gains Shanghai Stock Exchange acceptance for STAR Market A-share IPO","media":"Bulletin Express","content":"<p>Duality Biotherapeutics, Inc. announced that the Shanghai Stock Exchange (SSE) has formally accepted the company’s application materials for an initial public offering of RMB ordinary shares (A Shares) on the Science and Technology Innovation Board (STAR Market). The submission includes the “Initial Public Offering of RMB Ordinary Shares (A Shares) and Listing on the Science and Technology Innovation Board Prospectus (Application Proof),” which will be available on the SSE website.</p>\n<p>The proposed RMB Share Issue remains subject to subsequent regulatory approvals and therefore may or may not proceed. Duality Biotherapeutics emphasized that shareholders and potential investors should exercise caution when dealing in the company’s shares.</p>\n<p>Further updates will be released in accordance with Hong Kong Listing Rules and other applicable regulations.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Duality Biotherapeutics gains Shanghai Stock Exchange acceptance for STAR Market A-share IPO</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDuality Biotherapeutics gains Shanghai Stock Exchange acceptance for STAR Market A-share IPO\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-06-12 22:42</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Duality Biotherapeutics, Inc. announced that the Shanghai Stock Exchange (SSE) has formally accepted the company’s application materials for an initial public offering of RMB ordinary shares (A Shares) on the Science and Technology Innovation Board (STAR Market). The submission includes the “Initial Public Offering of RMB Ordinary Shares (A Shares) and Listing on the Science and Technology Innovation Board Prospectus (Application Proof),” which will be available on the SSE website.</p>\n<p>The proposed RMB Share Issue remains subject to subsequent regulatory approvals and therefore may or may not proceed. Duality Biotherapeutics emphasized that shareholders and potential investors should exercise caution when dealing in the company’s shares.</p>\n<p>Further updates will be released in accordance with Hong Kong Listing Rules and other applicable regulations.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"09606","symbol_name":"映恩生物-B","start_time":0,"source_url":"","article_id":"1198994923","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1198994923","pubTimestamp":1781275371,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Duality Biotherapeutics, Inc. announced that the Shanghai Stock Exchange (SSE) has formally accepted the company’s application materials for an initial public offering of RMB ordinary shares (A...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"09606":"映恩生物-B"},"translate_title":"Duality Biotherapeutics获得上交所科创板A股IPO受理","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"09606":1},"content_text":"Duality Biotherapeutics, Inc. announced that the Shanghai Stock Exchange (SSE) has formally accepted the company’s application materials for an initial public offering of RMB ordinary shares (A Shares) on the Science and Technology Innovation Board (STAR Market). The submission includes the “Initial Public Offering of RMB Ordinary Shares (A Shares) and Listing on the Science and Technology Innovation Board Prospectus (Application Proof),” which will be available on the SSE website.\nThe proposed RMB Share Issue remains subject to subsequent regulatory approvals and therefore may or may not proceed. Duality Biotherapeutics emphasized that shareholders and potential investors should exercise caution when dealing in the company’s shares.\nFurther updates will be released in accordance with Hong Kong Listing Rules and other applicable regulations.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1198994923","isCrawlerRequest":true}